Well, they did do the $9m raise at 2.10 not long ago. I think the fear is, where does the money come from for the eventual bigger trials? For some reason one little biotech will get a huge bid at this stage and be in the hundreds or billion dollar market cap, and others like us dont. We have what would be blockbuster breakthroughs if they pan out. If we 'got a bid' we could sell shares and dilute little. But to raise 100m right now would wipe us out.
Trials take huge money, and we dont have it.
News 
Market Data 
Discover 
AI
